PreciGenome
PrivateCompany Overview
PreciGenome is a life sciences company that develops microfluidic technology, PCR systems, and lipid nanoparticle synthesis solutions for pharmaceutical and diagnostic applications.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Drug Discovery, Precision Medicine, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PreciGenome Comparables
Compare PreciGenome with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Inside Therapeutics | 84% | |
| Danaher | 81% | |
| Hangzhou TinkerBio Technology Co., Ltd. | 79% | |
PreciGenome Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 22, 2024
Grew 43% QoQ, from 7 to 10 employees.
PreciGenome Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about PreciGenome's valuation, stock price, and market status.